What is the dosing regimen for NPH (Neutral Protamine Hagedorn) insulin and Regular (human insulin) insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

NPH insulin should be started at 10 units per day or 0.1-0.2 units/kg per day, with a goal of achieving target fasting plasma glucose (FPG) levels, and titrated based on individual needs, as recommended by the most recent guidelines 1. When initiating NPH insulin, it's essential to set a FPG goal and choose an evidence-based titration algorithm, such as increasing the dose by 2 units every 3 days to reach the FPG goal without causing hypoglycemia 1. Key considerations for NPH insulin dosing include:

  • Starting dose: 10 units per day or 0.1-0.2 units/kg per day
  • Titration algorithm: increase by 2 units every 3 days to reach FPG goal
  • Hypoglycemia management: lower dose by 10-20% if no clear cause is found Regular insulin dosing should be individualized, considering factors such as meal timing and carbohydrate intake. Some general principles for Regular insulin dosing include:
  • Administering Regular insulin 30 minutes before meals
  • Starting with a dose of 0.1-0.2 units/kg before breakfast and dinner
  • Adjusting the dose based on blood glucose monitoring results, with pre-meal targets of 80-130 mg/dL and post-meal targets below 180 mg/dL 1. It's crucial to assess the adequacy of insulin dose at every visit and consider clinical signals to evaluate for overbasalization and the need for adjunctive therapies, such as GLP-1 RAs or dual GIP and GLP-1 RAs, if A1C remains above goal 1.

From the Research

Dosing of N and R Insulin

  • The dosing of N (NPH) and R (regular) insulin can be initiated with a premixed 70/30 insulin administered twice daily, as studied in patients with type 2 diabetes 2.
  • For insulin initiation, a starting dose of 10 units or 0.2 units/kg can be used, with an increase of 2 units every 3 days until fasting levels are consistently in the target range 3.
  • The use of premix insulin analogs, such as 70/30 insulin, has been shown to improve postprandial glycemic control and health-related quality of life without increasing the frequency of hypoglycemic events 2.
  • When using NPH insulin, it can be administered twice daily, with a potential reduction in hypoglycemic events compared to premixed insulin analogs 4.
  • Regular insulin can be administered before each meal, with intermediate insulin administered at bedtime, to maintain blood glucose levels within a target range 5.

Titration and Adjustment

  • Insulin doses can be adjusted based on fasting blood glucose levels, with a reduction of 4 units if hypoglycemia occurs 3.
  • The titration of insulin doses should be individualized to each patient, taking into account their specific needs and response to therapy 6.
  • The use of self-monitoring of blood glucose levels can help guide insulin dose adjustments and improve glycemic control 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effect of premixed nph and regular insulin on glucose control and health-related quality of life in patients with type 2 diabetes mellitus.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 1997

Research

[When and why start insulin in type 2 diabetes?].

La Revue du praticien, 2015

Research

Once-daily insulin glargine compared with twice-daily NPH insulin in patients with type 1 diabetes.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2004

Research

Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.